Sangamo reports 3Q loss

RICHMOND, Calif. (AP) _ Sangamo Therapeutics Inc. (SGMO) on Thursday reported a loss of $12.4 million in its third quarter.

The Richmond, California-based company said it had a loss of 15 cents per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share.

The drug developer posted revenue of $11.8 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $9.4 million.

Sangamo expects full-year revenue in the range of $30 million to $40 million.

Sangamo shares have more than quadrupled since the beginning of the year. In the final minutes of trading on Thursday, shares hit $12.30, more than tripling in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGMO at https://www.zacks.com/ap/SGMO